The expanding range of autoimmune disorders of the nervous system

The Lancet Neurology

Volumn 12, Issue 1, 2013, Pages 22-24

  Wildemann, Brigitte ^a   Jarius, Sven ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AQUAPORIN 4; AQUAPORIN 4 ANTIBODY; AQUAPORUMAB; ECULIZUMAB; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; MONOCLONAL ANTIBODY; TOCILIZUMAB; UNCLASSIFIED DRUG;

ATAXIA; AUTOIMMUNE DISEASE; DISEASE COURSE; ENCEPHALITIS; HODGKIN DISEASE; HUMAN; IMMUNE RESPONSE; IMMUNOASSAY; MORTALITY; MYELITIS; MYELOOPTIC NEUROPATHY; NEUROIMMUNOLOGY; NOTE; OPTIC NEURITIS; PATHOGENESIS; PRIORITY JOURNAL; SEX DIFFERENCE; T LYMPHOCYTE;

ANIMALS; AUTOANTIBODIES; AUTOIMMUNE DISEASES OF THE NERVOUS SYSTEM; HUMANS; NEUROMYELITIS OPTICA; RECEPTORS, CHOLINERGIC;

EID: 84870843421     PISSN: 14744422     EISSN: 14744465     Source Type: Journal    
DOI: 10.1016/S1474-4422(12)70301-0     Document Type: Note

References (16)

1. Lennon VA, Wingerchuk DM, Kryzer TJ, et al. A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet 2004, 364:2106-2112.
2. Kitley J, Leite MI, Nakashima I, et al. Prognostic factors and disease course in aquaporin-4 antibody-positive patients with neuromyelitis optica spectrum disorder from the United Kingdom and Japan. Brain 2012, 135:1834-1849.
3. Jarius S, Ruprecht K, Wildemann B, et al. Contrasting disease patterns in seropositive and seronegative neuromyelitis optica: a multicentre study of 175 patients. J Neuroinflammation 2012, 9:14.
4. Waters PJ, McKeon A, Leite MI, et al. Serologic diagnosis of NMO: a multicenter comparison of aquaporin-4-IgG assays. Neurology 2012, 78:665-671.
5. Kitley J, Woodhall M, Waters P, et al. Myelin-oligodendrocyte glycoprotein antibodies in adults with a neuromyelitis optica phenotype. Neurology 2012, 79:1273-1277.
6. Rostasy K, Mader S, Hennes EM, et al. Persisting MOG antibodies in AQP-4 antibody negative pediatric neuromyelitis optica. Mult Scler (in press).
7. Mader S, Gredler V, Schanda K, et al. Complement activating antibodies to myelin oligodendrocyte glycoprotein in neuromyelitis optica and related disorders. J Neuroinflammation 2011, 8:184.
8. Varrin-Doyer M, Spencer CM, Schulze-Topphoff U, et al. Aquaporin 4-specific T cells in neuromyelitis optica exhibit a Th17 bias and recognize Clostridium ABC transporter. Ann Neurol 2012, 72:53-64.
9. Pittock SJ, McKeon A, Mandrekar JN, Weinshenker BG, Lucchinetti CF, Wingerchuk DM. Pilot clinical trial of eculizumab in AQP4-Ig-G-positive NMO. 2012 Annual Meeting of the American Neurological Association; Boston, MA; Oct 9, 2012. Abstract T1826.
10. Boronat A, Gelfand JM, Gresa-Arribas N, et al. Encephalitis and antibodies to DPPX, a subunit of Kv4.2 potassium channels. Ann Neurol (in press).
11. Srivastava R, Aslam M, Kalluri SR, et al. Potassium channel KIR4.1 as an immune target in multiple sclerosis. N Engl J Med 2012, 367:115-123.
12. de Graaff E, Maat P, Hulsenboom E, et al. Identification of delta/notch-like epidermal growth factor-related receptor as the Tr antigen in paraneoplastic cerebellar degeneration. Ann Neurol 2012, 71:815-824.
13. Prüss H, Finke C, Höltje M, et al. NMDA receptor antibodies in herpes simplex encephalitis. Ann Neurol (in press).
14. Prüss H, Holtje M, Maier N, et al. IgA NMDA receptor antibodies are markers of synaptic immunity in slow cognitive impairment. Neurology 2012, 78:1743-1753.
15. Pevzner A, Schoser B, Peters K, et al. Anti-LRP4 autoantibodies in AChR- and MuSK-antibody-negative myasthenia gravis. J Neurol 2012, 259:427-435.
16. Zhang B, Tzartos JS, Belimezi M, et al. Autoantibodies to lipoprotein-related protein 4 in patients with double-seronegative myasthenia gravis. Arch Neurol 2012, 69:445-451.